Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22-Reference-Cited by-同舟云学术

Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22

Published:2022-11-29 Issue:1 Volume:17 Page:
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Resp Viruses

Author:

Gandhi‐Banga Sonja¹^ORCID,Wague Sophie²,Shrestha Anju³⁴,Syrkina Olga³,Talanova Oxana²,Nissilä Markku⁵,Stuff Karl⁶,Monfredo Céline⁷

Affiliation:

1. Sanofi Toronto ON Canada

2. Sanofi Lyon France

3. Sanofi Swiftwater Pennsylvania USA

4. Affiliation at the time of the study; current affiliation Regeneron Pharmaceuticals Basking Ridge New Jersey USA

5. Terveystalo Biobank and Clinical Research Turku Finland

6. Arztpraxis Dr. Stuff Donaueschingen Germany

7. Global Biostatistical Sciences, Sanofi Marcy l'Etoile France

Funder

Sanofi

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.13071

Reference21 articles.

1. Pharmacovigilance risk assessment committee (PRAC) EMA.Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU 2014[cited2014April 10]; Available from:https://www.ema.europa.eu/en/documents/scientific-guideline/interim-guidance-enhanced-safety-surveillance-seasonal-influenza-vaccines-eu_en.pdf

2. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety

3. Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria;Clothier HJ;Commun Dis Intell Q Rep,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Communiqué. Vaccination « haute dose » contre la grippe : un progrès dans la protection des seniors qui doit être préservé;Bulletin de l'Académie Nationale de Médecine;2024-08

2. High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults;Influenza and Other Respiratory Viruses;2024-04

3. Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season;Human Vaccines & Immunotherapeutics;2024-03-06

4. Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine;Human Vaccines & Immunotherapeutics;2023-08

5. Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea;Infectious Diseases and Therapy;2023-06